Policy/Enforcement News
Threat Alert: Medicine designed to mimic regulated pharmaceuticals for sale online at Etsy.com
In spite of Etsy’s terms of use, there is a thriving trade in chemicals on the site, including those sold to individuals seeking homemade versions of highly regulated pharmaceuticals.
[...]How low PBM reimbursements ultimately endanger US patients
Pharmacy benefit managers have created an economic climate that encourages the sale of fake and diverted medicines by systematically under reimbursing pharmacies.
[...]Colorado updates drug importation proposal, cuts list of meds by 88, adds Ozempic
Colorado’s updated Canadian drug importation application to the FDA cuts the drug list from 112 to 24 and adds Ozempic to the list of medicines it wants from Canadians.
[...]DEA tells e-commerce companies they have compliance obligations for pill press sales on their platforms.
The DEA put all e-commerce platforms on notice of their obligations whenever they facilitate transactions involving pill presses.
[...]Partnership for Safe Medicines Condemns the Weakening of the U.S. Drug Supply through Canadian Drug Importation + Full coverage of decision
PSM’s statement on the FDA decision and full coverage including media stories, official documents, and statements from stakeholders.
[...]PSM files a supplement to citizen petition opposing Florida’s importation proposal
In September, the Partnership for Safe Medicines and others filed a supplement to our 2021 Citizen’s Petition asking the U.S. Department of Health and Human Services not to authorize Florida’s Canadian Drug Importation Plan.
[...]Cooper Davis Act (S.1080) to have minimal fiscal impact.
For those following the Cooper Davis Act (S.1080) which would require social media platforms to report drug dealing when they discover it, the Congressional Budget Office has analyzed the legislation and said it will “not significantly increase net direct spending” and “not increase on-budget deficits”.
[...]September 18, 2023: USFDA concerned that eight companies, including two pharmacies, are illegally marketing unapproved ophthalmic drug products
USFDA is concerned that eight companies, including two pharmacies, are illegally marketing unapproved ophthalmic drug products that pose a heightened risk to users. Counterfeit pills make the DHS’ threat assessment list for 2024.
[...]Partnership for Safe Medicines Applauds Senate HELP Committee Vote to Table Harmful Drug Importation Amendment But Remains Concerned About Current Importation Proposals
Washington, DC (June 17, 2022) – Shabbir Safdar, executive director of The Partnership for Safe Medicines, released the following statement today: “The U.S. Senate Committee on Health, Education, Labor & Pensions’ 15-7 vote against Senator Sanders’ foreign drug importation amendment to S. 4348, the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, is…
[...]Take Action: Ask congress to require domain name sellers to take down websites that sell drugs illegally
The “Domain Reform for Unlawful Drug Sellers” or “DRUGS” Act would require domain name sellers to lock and suspend websites when regulators or law enforcement show evidence that they are selling drugs illegally.
This would be a game changer for patient safety.